Voyager taps Brammer and Fujifilm for gene therapy development program

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/daizuoxin)
(Image: Getty/daizuoxin)

Related tags: CDMO, Brammer Bio, Fujifilm diosynth biotechnologies, Gene therapy, Manufacturing

The clinical-stage gene therapy company Voyager Therapeutics has entered into collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies to expand its manufacturing capabilities.

Voyager will transfer its research and development production capabilities to the contract development and manufacturing organizations (CDMOs), which will support the development of its gene therapy programs, providing late-stage clinical and commercial-scale capabilities.

Voyager will lead early-stage development and scale-up before transferring the technology. The company’s manufacturing platform uses a baculovirus/Sf9 cell production process to produce clinical and commercial scale batches of adeno-associated virus (AAV) vectors.

The length of the collaboration has not specifically been disclosed, though it could be renewed based on meeting set milestones and other criteria, a spokesperson told us.

"Voyager plans to use [the CDMOs] to support the clinical development of its programs and if its programs are approved, for commercial supply,"​ they added.

In line with the collaboration announcement, Voyager will partner with Brammer to implement a commercial-ready manufacturing process under current good manufacturing practice (cGMP) at its Cambridge facility. At this facility and others, Brammer recently has completed a series of expansions​ as part of its three-year, $200m investment program.

Voyager also will partner with Fujifilm​ to provide first-in-human (FIH) cGMP clinical trial material production capacity at the CDMO’s College Station facility in Texas.

Related news

Show more

Related products

show more

Innovations in OSD

Innovations in OSD


This DFE series of educational webinars looks at innovations in Oral Solid Dose Forms with the emergence of advanced technologies such as Continuous Manufacturing...

Register for free

Covance Touchless Drug and Device Vigilance Vision

Covance Touchless Drug and Device Vigilance Vision

Covance Patient Safety | 01-Sep-2020 | Data Sheet

Automation tools enable organizations to identify patterns in structured and unstructured data and facilitate automation of the entire product vigilance...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Related suppliers

Follow us


View more